AKT1 and Parkinson disease: Ras-PI3K-Akt survival pathway activation could play a role in rasagiline's neuroprotective effect in post-1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism [56].